Release of the decoy oligonucleotides within the cell acts to bind up free NF-κB, thus effectively inhibiting transactivation of downstream target genes, leading to inhibition of GBM cell growth and proliferation [249,250]. Here, NFKB1 is linked to glioblastoma.